by Sydney Braun | May 14, 2025 | Uncategorized
Cell and gene therapy developers continually encounter significant hurdles during the fill & finish phase—challenges best illustrated by manual workflows that are prone to variability, risk of contamination, and limited scalability. This whitepaper, authored by...
by Sydney Braun | Dec 30, 2024 | Uncategorized
This summary is based on the original article, which can be found here. Cellipont Bioservices, a contract development and manufacturing organization (CDMO) specializing in cell therapy manufacturing, has entered into a strategic partnership with Xiogenix, a...
by Sydney Braun | Dec 30, 2024 | Uncategorized
This summary is based on the original press release, which can be found here. Xiogenix, a leader in biopharmaceutical technology, is excited to announce a strategic partnership with Cellipont Bioservices, a premier cell therapy Contract Development and Manufacturing...
